ClinicalTrials.gg
CompletedNCT06513845Updated Oct 19, 2026

Drum Circle Synchrony Study 2c.a.

An interventional study of Communal drumming recordings in Mental Health Issue and COVID-19, sponsored by Yale University. Completed at 2 sites in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by Yale University · Not applicable, Interventional, and Supportive care

How we know

Updated Oct 19, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
28
Allocation
Non-randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 20 studies in COVID-19 by Yale University — 1 open to participants now, 1 under way, none of them phase 3. COVID-19 · Yale University.

Enrollment
12th of 17
28 · median 63
Started
2024
with 5 others
No phase
11 of 20
1 open now
Registered
16th of 20
by date

Among the 20 studies in COVID-19 by Yale University, this one is the 12th largest by enrollment of the 17 interventional ones that give a count, is one of 6 that started in 2024, is one of 11 with no phase, and was the 16th registered.

COVID-19

7,996 studies on the registry are indexed under COVID-19; 469 are open to participants now.

Browse COVID-19 studies →

Open to participants now

1 of the 20 studies in COVID-19 by Yale University is open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

Where they have run

Who these studies take

Of the 356 COVID-19 studies recruiting now, 205 (58%) set no upper age limit and 84 (24%) stop at 75 or younger; 90 take children under 18; 135 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in COVID-19 by Yale University, or all of them as a file.
02

Study summary

Mental health vulnerability due to stress is increased in People of African Descent (PADs) in America due to disproportionate effects of racism, poverty, education, and criminal justice sentencing. Various meditation and mindfulness approaches have provided evidence of measured reductions in multiple negative dimensions of stress. However, the majority of these studies do not have an adequate representation of PADs or other marginalized groups and are not designed to be culturally relevant or community based. Music has been shown to alleviate multiple symptoms of stress and has been shown to be a preferred and effective support for meditation and mindfulness. However, its role in stress management in PADs engaged in meditation or mindfulness is seldom studied. This study aims to evaluate the effects of a virtual, community-based music mindfulness program on stress management in PAD community members with anxiety and depression during COVID19.

2c.a. Drum Circle Synchrony Study: This study will investigate the role that synchrony plays in subjective feelings of connection.

Read the detailed description

The investigators also propose a study to investigate the effects of communal drumming in reducing anxiety and increasing connectedness within drum circle community. Investigators hypothesize that these intervention will lead to reductions in scores on stress scales and will provide preliminary data for studies evaluating these types of community programs as an adjunct to the standard of care.

Musicians and non-musicians will listen to segments (\~30 sec duration) of recordings taken from the music made during a previous arm of drum circle and answer a survey. Segments will be categorized as highly synchronized or not synchronized.

03

Conditions studied

  • Mental Health Issue
  • COVID-19

Browse trials for

Keywords

  • Mindfulness
  • Meditation
  • Music
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ages 18 and older

Exclusion criteria

Exclusion Criteria:

  • ages 17 and younger
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
28 participants (actual)

Study arms

  • Experimental
    Musicians group

    Musicians will listen to segments (\~30 sec duration) of recordings taken from the music made during the previous drum circle and answer a survey asking how connected they felt while listening.Segments will be categorized as highly synchronized or not synchronized.

    Behavioral: Communal drumming recordings

  • Experimental
    Non-musicians group

    Non-musicians will listen to segments (\~30 sec duration) of recordings taken from the music made during the previous drum circle and answer a survey asking how connected they felt while listening.Segments will be categorized as highly synchronized or not synchronized..

    Behavioral: Communal drumming recordings

Interventions

  • BehavioralCommunal drumming recordings

    Segments (\~30 sec duration) of recordings taken from the music made during the previous drum circle. Segments will be categorized as highly synchronized

06

What researchers measure

Primary outcomes

  1. Mean score connectedness rating

    Mean connectedness rating survey assessed using a Likert scale total range of 1 (no connection) to 7 (maximum connection) for synchronous and asynchronous audio samples

    Time frame: measured during listening session (30minutes)

  2. Mean score subjective rating of synchrony

    Subjective ratings of synchrony will be assessed using a Likert scale with total score range from 1-5, with higher scores indicating more synchrony, for synchronous and asynchronous audio samples.

    Time frame: measured during listening session (30minutes)

07

Study locations

2 sites
  • BLOOM
    New Haven, Connecticut 06515, United States
  • Musical Intervention Studios
    New Haven, Connecticut 06520, United States
08

References and documents

Individual participant data

Plan to share: Yes — De-identified, aggregate data will be shared through pre-prints, publications, and community town hall meetings.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2024 to primary completion in Dec 2025, 16 months.

Of 1,337 non-industry interventional studies with no phase under COVID-19, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 20. This study's 16 months is above that.

Counting every sponsor, half of 1,475 studies reached it within 9 months; a quarter within 3 and three quarters within 19.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 19, 2026: primary completion Mar 2026 → Dec 2025 and completion Mar 2026 → Dec 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 10, 2024
First posted
Jul 22, 2024
StartActual
Aug 1, 2024
Primary completionActual
Dec 18, 2025was Mar 2026
CompletionActual
Dec 18, 2025was Mar 2026
Last update
Oct 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Enrolling by invitation→Completed
changed Oct 19, 2026
Primary completion
Mar 2026→Dec 18, 2025 (actual)
Oct 19, 2026
Study completion
Mar 2026→Dec 18, 2025 (actual)
Oct 19, 2026
Enrollment
30 (estimated)→28 (actual)
Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    Enrolling by invitation→Completed
    Primary completion Mar 2026→Dec 18, 2025 (now actual)
    Study completion Mar 2026→Dec 18, 2025 (now actual)
    Enrollment 30 (estimated)→28 (actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06513845
Lead sponsor
Yale University
Responsible party
Sponsor
First posted
Jul 22, 2024
Start date
Aug 1, 2024
Primary completion
Dec 18, 2025
Completion
Dec 18, 2025
Last update
Oct 19, 2026

Study contacts

AZA Allsop, MD, PhD
principal investigator · Yale University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion